Homologous and heterologous antibody production to Sindbis and Semliki Forest viruses in mice after immunization with brain passaged or chick embryo cell passaged Sindbis virus
The possibility that brain passaged Sindbis, as compared to CE cell monolayer passaged Sindbis, elicits a better humoral immune response and enhances cross protection in a heterologous and homologous system has been examined. Data from the in vivo and in vitro sectors of this investigation indicate that there is essentially no significant difference between the two vaccines; however, results from neutralizing antibody determinations suggest that the brain passage Sindbis is slightly more antigenic. The finding most significant in this study is the suppression of antibody production to the second, different virus given as challenge. This was found in both the neutralization and HAI assays. Animals immunized with Sindbis and challenged with SFV did not produce detectable antibody to SFV, although antibody was found in the sham immunized controls.
In summary, the data from in vivo and in vitro studies indicate the following:
(1) There is no distinct difference in the degree of cross protection conferred by HR Sindbis passaged in suckling mouse brain and HR Sindbis passaged in chick embryo cell monolayers.
(2) There is a possibility that the brain passaged Sindbis may be slightly more antigenic in causing the production of neutralizing antibody; however, there is no difference in response detected in HAI titers.
(3) There is no cross reactivity of antibodies in any experiment.
(4) There is no evidence of a HAI or neutralizing antibody anamnestic response with either the homologous or heterologous challenges.
(5) There is evidence of suppression of antibody production to SFV following an immunization with Sindbis virus.
Thesis78.S353.pdf
1.94 MB
Adobe PDF
46b0ff2eec59e2a70ef082a6902b90cb